ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981